Abstract | BACKGROUND: MATERIALS AND METHODS: Forty-eight female Swiss-Webster mice were divided into four groups. Group 1 received 50 microl of saline ip every hour for 6 h ( sham). Group 2 received saline treatment, plus Lexipafant (25 mg/kg dose ip, every 3 h starting 1 h after the first saline injection) ( sham/Lex). Group 3 received cerulein (50 microg/kg dose ip, every hour for 6 h) (AP). Group 4 received AP, plus therapeutic treatment with Lexipafant (AP/Lex). Animals were sacrificed 3 h after the last injection. Serum cytokine levels were determined by ELISA. Standard assays were performed for serum amylase activity and lung myeloperoxidase activity (MPO). Histology was scored by two blinded investigators. RESULTS: Serum cytokines (TNFalpha, IL-1beta), lung MPO, and serum amylase activity were reduced by PAF antagonism. Histology showed a trend toward improvement with Lexipafant, but did not reach statistical significance. CONCLUSION: The PAF antagonism reduces the severity of systemic inflammation when given after the induction of mild AP in mice. These results suggest that Lexipafant may be useful in the treatment of mild pancreatitis after its clinical onset.
|
Authors | J S Lane, K E Todd, B Gloor, C F Chandler, A W Kau, S W Ashley, H A Reber, D W McFadden |
Journal | The Journal of surgical research
(J Surg Res)
Vol. 99
Issue 2
Pg. 365-70
(Aug 2001)
ISSN: 0022-4804 [Print] United States |
PMID | 11469912
(Publication Type: Journal Article)
|
Copyright | Copyright 2001 Academic Press. |
Chemical References |
- Imidazoles
- Interleukin-1
- Platelet Activating Factor
- Tumor Necrosis Factor-alpha
- Peroxidase
- Amylases
- Leucine
- lexipafant
|
Topics |
- Acute Disease
- Amylases
(blood)
- Animals
- Disease Models, Animal
- Female
- Imidazoles
(pharmacology)
- Interleukin-1
(blood)
- Leucine
(analogs & derivatives, pharmacology)
- Lung
(immunology, metabolism)
- Mice
- Pancreatitis
(drug therapy, immunology, pathology)
- Peroxidase
(analysis)
- Platelet Activating Factor
(antagonists & inhibitors, immunology)
- Tumor Necrosis Factor-alpha
(metabolism)
|